factory Outlets for Cas No.29708-87-0,123483-19-2 - Cimifugin CAS No. 37921-38-3 – Yongjian
factory Outlets for Cas No.29708-87-0,123483-19-2 - Cimifugin CAS No. 37921-38-3 – Yongjian Detail:
Essential Information
[English Name] Cimifugin
[English Alias] (2S)-7-(Hydroxymethyl)-2-(2-hydroxypropan-2-yl)-4-methoxy-2,3-dihydrofuro[3,2-g]chromen-5-one; (2S)-7-(hydroxymethyl)-2-(2-hydroxypropan-2-yl)-4-methoxy-2,3-dihydro-5H-furo[3,2-g]chromen-5-one; 7-(hydroxymethyl)-2-(1-hydroxy-1-methylethyl)-4-methoxy-2,3-dihydro-5H-furo[3,2-g]chromen-5-one [1]
[molecular formula] C16H18O6
[molecular weight] 306.31052
[CAS No.] 37921-38-3
[chemical classification] chromones chromogen ketones
[source] cimicfuga goetida L
[Specification] > 98%
[character] white powder
Customized Service of Chemical Reference Materials of Traditional Chinese Medicine
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd. is mainly engaged in the basic research of active substances of traditional Chinese medicine for more than ten years. So far, the company has conducted in-depth research on more than 100 kinds of commonly used traditional Chinese medicine, and extracted thousands of chemical components.
The company has top R & D personnel and perfect testing and analysis equipment in the industry, and has served hundreds of scientific research institutions. It can quickly and efficiently meet customer needs.
Drug Impurity Separation, Preparation and Structure Confirmation Service
Impurities in drugs are closely related to the quality, safety and stability of drugs. The preparation and structure confirmation of impurities in drugs can help us understand the ways of impurities and provide a basis for the improvement of production process. Therefore, the preparation and separation of impurities is of great significance to drug research and development.
However, the content of impurities in the drug is low, the source is wide, and the structure is mostly similar to the principal component. What technology can be used to quickly separate and purify all impurities in the drug one by one? What techniques and methods are used to confirm the structure of these impurities? This is the difficulty and challenge faced by many pharmaceutical units, especially the pharmaceutical enterprises of plant medicine and Chinese patent medicine.
Based on such needs, the company has launched drug impurity separation and purification services. Relying on nuclear magnetic resonance, mass spectrometry and other equipment and technologies, the company can quickly identify the structure of the separated compounds, so as to meet the needs of customers.
SPF Animal Experiment
The construction area of the animal experimental area is 1500 square meters, including 400 square meters of SPF level experimental area and 100 square meters of P2 level cell laboratory. Led by scientists of China Pharmaceutical University, it forms a core technical team with a number of returnees. Provide high-quality animal models, experimental design, overall projects and other services for biomedical scientific research, teaching and industrial development.
Product detail pictures:
Related Product Guide:
Gaining purchaser gratification is our firm's intention eternally. We will make wonderful endeavours to build new and top-quality merchandise, satisfy your exclusive needs and provide you with pre-sale, on-sale and after-sale products and services for factory Outlets for Cas No.29708-87-0,123483-19-2 - Cimifugin CAS No. 37921-38-3 – Yongjian , The product will supply to all over the world, such as: California, Poland, Czech Republic, We only supply quality items and we believe this is the only way to keep business continue. We can supply custom service too such as Logo, custom size, or custom merchandise etc that can according to customer's requirement.
By Heloise from kazan - 2018.12.10 19:03
The customer service staff is very patient and has a positive and progressive attitude to our interest, so that we can have a comprehensive understanding of the product and finally we reached an agreement, thanks!
By Martin Tesch from Germany - 2017.08.18 18:38